Dennis McGonagle PhD FRCPI
University of Leeds
H-index: 107
Europe-United Kingdom
Top articles of Dennis McGonagle PhD FRCPI
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update | Annals of the rheumatic diseases | Stephanie Shoop-Worrall | 2024/2/26 |
E069 Bimekizumab maintained efficacy responses through 52 weeks in patients with psoriatic arthritis and inadequate response or intolerance to tumour necrosis factor inhibitors … | William R Tillett Joseph F Merola Yoshiya Tanaka Ennio G Favalli Dennis McGonagle | 2024/4/1 | |
E072 The psoriatic arthritis disease activity score demonstrates excellent test-retest reliability in early, untreated psoriatic arthritis | Gabriele De Marco Elizabeth MA Hensor Dennis G McGonagle Ai Lyn Tan Laura C Coates | 2024/4/1 | |
Towards early diagnosis of axial psoriatic arthritis | Abdulla Watad Dennis McGonagle | 2024/1/22 | |
Poly‐Refractory Rheumatoid Arthritis: An Uncommon Subset of Difficult to Treat Disease With Distinct Inflammatory and Noninflammatory Phenotypes | NaN | Paula David Andrea Di Matteo Or Hen Shouvik Dass Helena Marzo‐Ortega | 2023 |
Association between enthesitis/dactylitis resolution and patient-reported outcomes in guselkumab-treated patients with psoriatic arthritis | Clinical rheumatology | Proton Rahman Iain B McInnes Atul Deodhar Georg Schett Phillip J Mease | 2024/3/12 |
PRELIMINARY EVIDENCE THAT SYNOVIAL MEMBRANE MESENCHYMAL STEM CELL MOBILISATION INTRAOPERATIVELY WITH NOVEL STEM CELL-MOBILIZING DEVICE MAY FACILITATE JOINT REPAIR POST … | Osteoarthritis and Cartilage | Ala Altaie Thomas Baboolal Owen Wall Sanjeev Ananad Emma Rowbotham | 2024/4/1 |
P176 Ixekizumab significantly improves nail disease and adjacent joint tenderness and swelling in psoriatic arthritis | Dennis McGonagle Arthur Kavanaugh Iain McInnes Lars-Erik Kristensen Joseph Merola | 2024/4/1 | |
E011 Magnetic resonance imaging in axial spondyloarthritis: usage, reporting times and scanning times-a service evaluation in a large tertiary centre | Jake Weddell Rahul Shah Philip Robinson Andrew Barr Claire Vandevelde | 2024/4/1 | |
Recent advances and evolving concepts in Still’s disease | Piero Ruscitti Luca Cantarini Peter A Nigrovic Dennis McGonagle Roberto Giacomelli | 2024/1/11 | |
Systematic review and meta-analysis of pharmacological interventions in adult-onset Still's disease highlights the beneficial role of biologic DMARDs | Journal of autism and developmental disorders | Brian Reichow Fred R Volkmar Michael H Bloch | 2013/10/1 |
Time to address the challenge of difficult to treat psoriatic arthritis: results from an international survey | Annals of the Rheumatic Diseases | Helena Marzo-Ortega Stephanie Rose Harrison György Nagy Pedro M Machado Dennis G McGonagle | 2024/3/1 |
Risk of developing psoriatic arthritis in psoriasis cohorts with arthralgia: exploring the subclinical psoriatic arthritis stage | RMD open | Alen Zabotti Filippo Fagni Laure Gossec Ivan Giovannini Michael Sticherling | 2024/4/1 |
E067 Bimekizumab maintained efficacy responses through 52 weeks in biologic disease-modifying antirheumatic drugnaïve patients with psoriatic arthritis who were responders at … | William R Tillett Joseph F Merola Yoshiya Tanaka Ennio G Favalli Dennis McGonagle | 2024/4/1 | |
P170 Ixekizumab significantly improved quality of life and joint pain in patients with psoriatic arthritis, nail disease and distal interphalangeal joint involvement from … | Christopher Ritchlin Arthur Kavanaugh Lars Erik Kristensen Joseph Merola Bruce Strober | 2024/4/1 | |
Enthesitis in patients with psoriatic arthritis treated with secukinumab or adalimumab: a post hoc analysis of the EXCEED study | Rheumatology | Gurjit S Kaeley Georg Schett Philip G Conaghan Dennis McGonagle Frank Behrens | 2024/1/1 |
Systematic Review and Metaanalysis of Pharmacological Interventions in Adult-Onset Still Disease and the Role of Biologic Disease-Modifying Antirheumatic Drugs | Piero Ruscitti Dennis McGonagle Viviam Canon Garcia Hilde Rabijns Katrin Toennessen | 2024/2/1 | |
Real-world experience of IL-17Ai drug survival in a large cohort of axial spondyloarthritis and psoriatic arthritis | Rheumatology Advances in Practice | Jake Weddell Naw Ra Aung Din Stephanie R Harrison Xabier Michelena Dennis McGonagle | 2024/1/1 |
High prevalence of radiographic erosions in early, untreated PsA: results from the SpARRO cohort | RMD open | Or Hen Andrea Di Matteo Sayam R Dubash Gabriele De Marco Ai Lyn Tan | 2024/4/1 |
E070 Sustained and consistent efficacy of bimekizumab in patients with active psoriatic arthritis regardless of prior TNF-inhibitor status: results from the phase 3 BE OPTIMAL … | William R Tillett Barbara Ink Rajan Bajracharya Vanessa Taieb Poonam Sharma | 2024/4/1 |
Co-Authors
